21.37

1.81% 0.38

After Hours: 21.37

Viridian Therapeutics Inc (VRDN)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Viridian Therapeutics Inc stock is traded at $21.37, with a volume of 680.48K. It is up +1.81% in the last 24 hours and up +13.25% over the past month. Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Previous Close:

$20.99

Open:

$21

24h Volume:

680.48K

Relative Volume:

0.89

Market Cap:

$1.75B

Revenue:

$305.00K

Net Income/Loss:

$-328.98M

P/E Ratio:

-5.5796

EPS:

-3.83

Net Cash Flow:

$-309.60M

1W Performance:

+2.59%

1M Performance:

+13.25%

6M Performance:

+77.79%

1Y Performance:

-9.56%

1-Day Range:

$20.75

$21.73

1-Week Range:

$20.75

$22.36

52-Week Range:

$9.90

$27.20

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Name

Viridian Therapeutics Inc

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

617.272.4600

Address

221 CRESCENT STREET, WALTHAM

Employee

143

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

VRDN's Discussions on Twitter

Compare VRDN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VRDN Viridian Therapeutics Inc	21.37	1.71B	305.00K	-328.98M	-309.60M	-3.83
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-25-25	Resumed	Jefferies	Buy
Dec-19-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Nov-25-24	Initiated	TD Cowen	Buy
Sep-11-24	Reiterated	Needham	Buy
Jun-11-24	Initiated	Wolfe Research	Outperform
Jun-06-24	Initiated	Goldman	Buy
May-09-24	Downgrade	B. Riley Securities	Buy → Neutral
May-09-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-14-23	Initiated	BTIG Research	Buy
Jun-14-23	Resumed	Credit Suisse	Outperform
May-30-23	Initiated	RBC Capital Mkts	Outperform
Apr-17-23	Initiated	Wells Fargo	Overweight
Mar-30-23	Initiated	Stifel	Buy
Dec-19-22	Initiated	Cowen	Outperform
Dec-19-22	Initiated	Needham	Buy
Dec-16-22	Initiated	Credit Suisse	Outperform
Dec-01-22	Initiated	H.C. Wainwright	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Nov-18-21	Initiated	SVB Leerink	Outperform
Oct-12-21	Initiated	Evercore ISI	Outperform
Jan-25-21	Initiated	Ladenburg Thalmann	Buy

View All

Viridian Therapeutics Inc Stock (VRDN) Latest News

11:49 AM

Is Viridian Therapeutics Inc. stock reversal real or fakeJuly 2025 Action & Daily Volume Surge Signals - newser.com

11:49 AM

11:39 AM

Tools to monitor Viridian Therapeutics Inc. recovery probability2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com

11:39 AM

11:20 AM

What machine learning models say about Viridian Therapeutics Inc.Recession Risk & Consistent Growth Stock Picks - newser.com

11:20 AM

10:48 AM

Is this a good reentry point in Viridian Therapeutics Inc.2025 Volatility Report & Fast Entry High Yield Tips - newser.com

10:48 AM

10:09 AM

Using Ichimoku Cloud for Viridian Therapeutics Inc. technicals2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com

10:09 AM

09:58 AM

What candlestick patterns are forming on Viridian Therapeutics Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com

09:58 AM

09:44 AM

Can machine learning forecast Viridian Therapeutics Inc. recoveryJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com

09:44 AM

08:46 AM

Is Viridian Therapeutics Inc. building a consolidation baseMarket Trend Review & Weekly Momentum Stock Picks - newser.com

08:46 AM

04:26 AM

Is Viridian Therapeutics Inc. stock attractive for growth ETFsMarket Movement Recap & Fast Entry Momentum Alerts - newser.com

04:26 AM

Oct 12, 2025

Why Viridian Therapeutics Inc. is moving todayWeekly Trade Recap & Scalable Portfolio Growth Methods - newser.com

Oct 12, 2025

Oct 11, 2025

Is Viridian Therapeutics Inc. (1S1) stock protected from inflationMarket Risk Report & Pattern Based Trade Signal System - newser.com

Oct 11, 2025

Viridian Therapeutics’ (VRDN) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025

Oct 10, 2025

Is Viridian Therapeutics Inc. stock safe for conservative investors2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com

Oct 10, 2025

Viridian Therapeutics supports key conferences with sponsorship initiative - Traders Union

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat

Oct 09, 2025

How Viridian Therapeutics Inc. stock reacts to bond yieldsQuarterly Market Review & High Return Trade Opportunity Guides - newser.com

Oct 09, 2025

Oct 06, 2025

Real time alert setup for Viridian Therapeutics Inc. performanceBear Alert & Real-Time Volume Surge Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Is Viridian Therapeutics Inc. stock dividend yield sustainable2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com

Oct 05, 2025

Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com

Oct 05, 2025

Oct 04, 2025